Literature DB >> 6610514

Effects of 12-o-tetradecanoyl-phorbol-13-acetate (TPA) on the colony growth of human T lymphocytes.

R Foa, P Lusso, M T Fierro, M C Giubellino, M L Ferrando, L Pegoraro.   

Abstract

The T colony promoting activity of 12-o-tetradecanoyl-phorbol-13-acetate (TPA) was assessed in a double layer culture assay which is dependent on the simultaneous presence of phytohaemagglutinin (PHA) and a leucocyte rich underlayer. TPA (10(-8) M) incorporated in the overlayer in place of PHA was capable of promoting T cell growth in the form of clusters in all 37 experiments performed and in the form of colonies in more than 50% of the samples tested. However, the T colony promoting activity of TPA alone was markedly less evident and consistent than that of PHA (mean 13 +/- 19.9 s.d. colonies vs 168 +/- 78.6). TPA concentrations of 10(-6) M, 10(-9) M and 10(-10) M were practically ineffective. On the other hand, the number of colonies obtained when both TPA 10(8) M and PHA were incorporated in the overlayer was significantly higher (P less than 0.01) than that observed with PHA alone (mean 250 +/- 108.2 vs 178 +/- 84.5 colonies). When TPA concentrations of 10(-9) M and 10(-10) M were used in addition to PHA, the enhancing effect was less evident, while an inhibition of T colony growth was observed with TPA 10(-6) M + PHA. TPA 10(-8) M was also capable of enhancing T colony growth when incorporated in the leucocyte rich underlayer (222 +/- 98.6 vs 172 +/- 80.9 colonies). In all cultures with TPA the peak of growth was delayed compared with that of control experiments with PHA. These findings demonstrate that TPA, particularly when co-cultured with PHA, is an effective T colony promoting agent. The observation that the number of colonies formed in the presence of TPA plus PHA is higher than the sum of those observed with the two stimulators independently, suggests that their synergistic effect may be mediated via the production of colony stimulating soluble factors.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6610514      PMCID: PMC1536234     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  Long term culture of tumour-specific cytotoxic T cells.

Authors:  S Gillis; K A Smith
Journal:  Nature       Date:  1977-07-14       Impact factor: 49.962

2.  Signal requirements for T lymphocyte activation. I. Replacement of macrophage function with phorbol myristic acetate.

Authors:  D L Rosenstreich; S B Mizel
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

3.  Synergistic action of phorbol esters in mitogen-activated bovine lymphocytes.

Authors:  A M Mastro; G C Mueller
Journal:  Exp Cell Res       Date:  1974-09       Impact factor: 3.905

4.  Relationship of cell cycle to recovery of IL 2 activity from human mononuclear cells, human and mouse T cell lines.

Authors:  B M Stadler; S F Dougherty; J J Farrar; J J Oppenheim
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

5.  A characterization of T lymphocyte colony-forming cells (TL-CFC) in human bone marrow.

Authors:  K Swart; B Löwenberg
Journal:  Clin Exp Immunol       Date:  1980-09       Impact factor: 4.330

6.  Reduced T-colony forming capacity by T-lymphocytes from B-chronic lymphocyte leukaemia.

Authors:  R Foa; D Catovsky; F Lauria; D A Galton
Journal:  Br J Haematol       Date:  1980-12       Impact factor: 6.998

7.  Phorbol-ester-mediated induction and augmentation of mitogenesis and interleukin-2 production in human T-cell lymphoproliferative disease.

Authors:  F A Vyth-Dreese; H J van der Reijden; J E de Vries
Journal:  Blood       Date:  1982-12       Impact factor: 22.113

8.  T-lymphocyte colonies in normal blood, bone marrow and lymphoproliferative disorders.

Authors:  R Foa; D Catovsky
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

9.  Inhibition of the mixed lymphocyte proliferative response by phorbol esters.

Authors:  A M Mastro; G C Mueller
Journal:  Biochim Biophys Acta       Date:  1978-01-26

10.  Phorbol myristate acetate: a mitogen selective for a T-lymphocyte subpopulation.

Authors:  J L Touraine; J W Hadden; F Touraine; E M Hadden; R Estensen; R A Good
Journal:  J Exp Med       Date:  1977-02-01       Impact factor: 14.307

View more
  1 in total

1.  Effect of phorbol myristate acetate on T cell colony formation, interleukin-2 (IL-2) receptor expression and IL-2 production by cells from patients at all stages of HIV infection.

Authors:  M Allouche; Y Lunardi-Iskandar; C Varela-Millot; M Itzhaki; P Cornuet; P Meyer; C Jasmin; V Georgoulias
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.